NEWARK, NJ – Usama Malik, the former chief financial officer of a New Jersey-based biopharmaceutical company, pled guilty to insider trading charges last week. The charges were made in relation to a scandal involving the undisclosed advance knowledge of a promising new drug’s clinical trial results. Malik admitted in Newark…Read More
Insider Trading Scandal Former New Jersey CFO Pleads Guilty
